Coronavirus LIVE Updates: Mumbai’s Lalbaugcha Raja Sarvajanik Ganeshotsav Mandal has determined to not maintain any of its well-known Ganesh Chaturthi festivities this yr in view of the COVID-19 pandemic. The organisers have determined to set-up a blood and plasma donation camp as a substitute. Meanwhile, India experiences 507 deaths and 18,653 new COVID-19 circumstances within the final 24 hours.
Coronavirus LATEST Updates: Mumbai’s Lalbaugcha Raja Sarvajanik Ganeshotsav Mandal has determined to not maintain any of its well-known Ganesh Chaturthi festivities this yr in view of the COVID-19 pandemic. The organisers have determined to set-up a blood and plasma donation camp as a substitute. India experiences 507 deaths and 18,653 new COVID-19 circumstances within the final 24 hours.
India on Wednesday reported 507 deaths and 18,653 new COVID-19 circumstances within the final 24 hours, taking the variety of constructive circumstances to five,85,493 together with 2,20,114 energetic circumstances, 3,47,979 cured/discharged/migrated and 17,400 deaths.
The Railways will develop its suburban providers in Mumbai from at this time and run 350 trains every within the Central and Western Railway Zones, Union Minister Piyush Goyal mentioned. The trains will, nevertheless, solely carry important providers personnel recognized by the Maharashtra authorities. Mumbai recorded 903 new circumstances, pushing the entire variety of circumstances to rise to 77,197 on Tuesday.
As Unlock-2 begins from Wednesday, India’s COVID-19 tally climbed to five,66,840 with practically 66 % circumstances reported in June alone. The nationwide toll rose to 16,893 with 418 new fatalities being reported in 24 hours, in keeping with the Union Health Ministry knowledge.
On Tuesday, Tamil Nadu once more surpassed Delhi to regain the second spot among the many listing of worst-hit states by the COVID-19 pandemic.
Meanwhile, Prime Minister Narendra Modi introduced an extension of the Pradhan Mantri Garib Kalyan Anna Yojana (PMGKAY), a authorities scheme, which goals to supply free ration for 80 crore folks, by 5 extra months until the top of November.
In his televised handle Tuesday, the prime minister additionally mentioned it’s a reason for fear that persons are not adhering as strictly to guidelines and precautions in the course of the ‘unlock’ section as they did in the course of the lockdown.
Modi proclaims extension of free ration scheme
Stating the price to the exchequer in extending the PMGKAY scheme, the prime minister mentioned that over Rs 90,000 crore will probably be spent on the scheme, and if the final three months’ expenditure on account of the free ration scheme is added, then the entire finances will probably be about Rs 1.5 lakh crore.
The scheme was rolled out for 3 months from April quickly after the nationwide lockdown was introduced to fight the COVID-19 pandemic.
Noting that July marks the start of the festive season when folks’s wants in addition to expenditure enhance, Modi mentioned that the federal government has determined to increase the scheme until November finish.
The prime minister additionally mentioned in his 16-minute handle that the Central Government is engaged on the “one nation, one ration card” initiative which, he added, will profit folks residing exterior their house for employment and different wants probably the most.
This was Modi’s sixth handle to the nation after the outbreak of the coronavirus pandemic
The prime minister mentioned that every member of a household coated beneath the scheme will get 5 kilogrammes of wheat or rice, and each household will get one kilogramme entire gram monthly as effectively.
Modi, nevertheless, lamented that there’s an rising “negligence” in private and social behaviour in the course of the easing of restrictions and urged folks to be extra vigilant.
“We have also seen that since ‘Unlock-1’, there is increasing negligence in personal and social behaviour. Earlier, we were very careful with respect to wearing of masks, social distancing and washing of hands for 20 seconds. But today, when we need to be more careful, increasing negligence is a cause of worry,” he mentioned and urged the folks to observe all vital precautions.
He additionally emphasised on strict enforcement of guidelines, particularly in containment zones.
“Those not following the rules will need to be stopped and cautioned,” he mentioned, stressing “be it a village pradhan or the prime minister, no one is above the law in India”.
Maharashtra, Tamil Nadu document most circumstances
Maharashtra remained the best contributor to the one day rise in circumstances, registering over 5,200 coronavirus infections, in keeping with the Union Health Ministry.
Recording practically 4,000 circumstances within the final 24 hours, Tamil Nadu has once more surpassed Delhi to regain the second spot among the many listing of worst-hit states by the pandemic.
Karnataka additionally recorded greater than 1,100 circumstances overtaking Haryana and Andhra Pradesh.
Delhi noticed a rise of two,084 circumstances up to now 24 hours. In June, the nationwide capital added over 64,000 contemporary circumstances to its tally, whereas over 47,357 sufferers recovered, had been discharged or migrated.
The whole variety of COVID-19 circumstances has gone as much as 15,394 in Telangana, 14,295 in Karnataka, 14,210 in Haryana, 13,891 in Andhra Pradesh, and 13,370 in Madhya Pradesh.
It has risen to 9,640 in Bihar, 7,752 in Assam, 7,237 in Jammu and Kashmir and 6,859 in Odisha. Punjab has reported 5,418 novel coronavirus infections to this point, whereas Kerala has 4,189 circumstances.
A complete of two,831 folks have been contaminated by the virus in Uttarakhand, 2,761 in Chhattisgarh, 2,426 in Jharkhand, 1,380 in Tripura, 1,227 in Manipur, 1,198 in Goa, 964 in Ladakh and 942 in Himachal Pradesh. Puducherry has recorded 619 COVID-19 circumstances, Chandigarh 435, Nagaland 434 and Dadra and Nagar Haveli and Daman and Diu collectively have reported 203 COVID-19 circumstances.
Arunachal Pradesh reported 187 circumstances, Mizoram has 148 circumstances, Andaman and Nicobar Islands has 90, Sikkim has registered 88 infections to this point, whereas Meghalaya has recorded 47 circumstances.
Delhi govt units ball rolling for ‘plasma financial institution’
The Delhi authorities has set the ball rolling to ascertain the first-of-its-kind “plasma bank” for therapy of COVID-19 at a facility within the National Capital and its modalities are being labored out, sources advised PTI.
The financial institution is being arrange on the Delhi government-run Institute of Liver and Biliary Sciences (ILBS) and medical doctors or hospitals must strategy it if a plasma is required for therapy of a COVID-19 affected person.
Addressing a web-based media briefing on Monday, Chief Minister Arvind Kejriwal had mentioned the financial institution will probably be operational within the subsequent two days.
The transfer comes as convalescent plasma remedy has proven “encouraging” leads to metropolis hospitals, he had mentioned.
Sources mentioned the power the place the plasma will probably be drawn from one particular person to donate to a COVID-19 affected person, is being arrange on the serving flooring of the ILBS.
The plasma itself may be saved within the blood financial institution facility in a separate pack, a supply mentioned.
According to specialists, plasma wants cryogenic storage at minus 80 levels Celsius or much less.
Bharat Biotech will get nod to conduct trials for vaccine
The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human scientific trials to develop an indigenous vaccine for COVID-19 — within the identify COVAXIN.
For this, Indian Council of Medical Research (ICMR) and BBIL had partnered to develop a completely indigenous vaccine for COVID-19 utilizing the virus pressure remoted at ICMR’s National Institute of Virology (NIV), Pune.
“The Central Drug Standard Control Organisation (CDSCO) — the office of DCGI has granted permission to initiate Phase I and II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020,” acknowledged the spokesperson of Bharat Biotech.
“The strain was successfully transferred from NIV to Bharat Biotech International Ltd. (BBIL). Work on vaccine development has been initiated between the two partners. ICMR-NIV are providing continuous support to BBIL for vaccine development. ICMR and BBIL will seek fast-track approvals to expedite vaccine development, subsequent animal studies and clinical evaluation of the candidate vaccine,” mentioned ICMR official.
With inputs from companies